Revenue is a critical financial metric, and Legend Biotech's worse-than-expected revenue report for Q3 is likely to negatively impact investor sentiment and the stock price in the short term. Given that revenue directly reflects a company's financial performance, this news is highly relevant and important to investors. The confidence in this analysis is high as financial reports are strong indicators of a company's performance and typically have a direct impact on stock prices.